Skip to main content
Clinical Trials/CTRI/2011/11/002127
CTRI/2011/11/002127
Not yet recruiting
Phase 3

Evaluation of safety and efficacy of adjuvant probiotics therapy in children with viral meningoencephalitis/ encephalitis: A randomized double blind controlled trial - PROVEC

India Council of Medical Research0 sites380 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Admitted with a diagnosis of viral encephalitis
Sponsor
India Council of Medical Research
Enrollment
380
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
India Council of Medical Research

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with acute encephalitis: Clinical definition : Any person, of any age, admitted to hospital with encephalopathy (altered level of consciousness persisting for \>24 h and including lethargy, irritability or a change in personality and behaviour) and \>\= 2 of the following :
  • 1\. Fever or history of fever (\>\=380 C) ;
  • 2\. seizures and/or focal neurological findings (with evidences of brain parenchymal involvement ) ;
  • 3\. CSF pleocytosis ( \> 4 WBC/ ml) ;
  • 4\. Electroencephalogram findings compatible with encephalitis ;
  • 5\. Abnormal results of neuroimaging in keeping with encephalitis.

Exclusion Criteria

  • Patients having risk factor of small intestinal bacterial overgrowth other than cirrhosis \- diabetes mellitus, history of abdominal surgery, immunomodulator drugs.
  • Patients with active gastrointestinal bleed, intestinal obstruction or peritonitis or any other reason to withhold oral drug administration.
  • Patients with advanced hepatocellular failure, renal failure and portal vein thrombosis
  • Patients with suspected or proven rabies
  • Diagnosed HIV positive or any other condition causing immune\-deficiency
  • Children with proven or suspected malignancies
  • Evaluation and laboratory testing

Outcomes

Primary Outcomes

Not specified

Similar Trials